Nebulizer treatment with Tyvaso (inhaled treprostinil) can improve exercise capacity in people with pulmonary hypertension associated with interstitial lung disease (PH-ILD), a study reports. The study, “Inhaled Treprostinil in Pulmonary Hypertension Due to Interstitial Lung Disease,” was published in The New England Journal of Medicine. ILD is a term that includes several conditions characterized by scarring (fibrosis) within the lungs. Often, ILD is complicated by pulmonary hypertension, or abnormally high pressure in the lung’s blood…

You must be logged in to read/download the full post.